R
Ruilongnuofu Medical Technology
Health Tech & Medtech · Minhang District, China · Founded 2019
Developing MIS and digital surgery solutions MoreLess
Shanghai-based Ronovo Surgical, operating under the full name Shanghai Ruilongnuofu Medical Technology Co., Ltd., was established in 2019 by co-founders John Ma and Dr. Ying Mao. John Ma, the company's CEO, brings extensive experience from the medical device industry, having held senior positions at Fosun Pharma and Intuitive Surgical. Dr. Ying Mao, the Chief Medical Officer, is a distinguished neurosurgeon and serves as the honorary president of Huashan Hospital, a prominent institution affiliated with Fudan University. This blend of commercial and clinical expertise has shaped the company's strategic direction.
Ronovo Surgical has positioned itself in the rapidly expanding market for robotic-assisted surgery, with an initial focus on mainland China. The company addresses the demand for advanced, yet more accessible, minimally invasive surgical options. Its business model centers on the development and sale of a proprietary surgical robotics platform, targeting hospitals and surgical centers. The primary revenue stream is expected from the sale of the Carina™ system and recurring sales of compatible surgical instruments and accessories.
The cornerstone of their offering is the Carina™ robotic surgical platform, a modular system designed for versatility in various soft tissue surgeries. This platform is composed of several key components: a primary laparoscopic surgical system, an advanced high-definition imaging system providing functional vision, and a comprehensive set of surgical instruments and accessories. A notable feature is its modularity, which allows for greater flexibility and adaptability in the operating room compared to single-unit systems. The system has successfully completed multi-center clinical trials in specialties such as gynecology and urology, leading to its clearance by China's National Medical Products Administration (NMPA) in early 2024.
Keywords: surgical robotics, medtech, minimally invasive surgery, Carina platform, NMPA approved, modular robotics, soft tissue surgery, medical devices, laparoscopy, healthcare technology
Company overview
Ruilongnuofu Medical Technology company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Minhang District, China
- Employees
- 43
- Open positions
- 11
- Dealroom signal
- 93.8
Valuation & funding
Ruilongnuofu Medical Technology funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Sep 2025 | $67M | $600M | Lilly Asia Ventures · INCE Capital · Granite Asia · Johnson & Johnson | ↗ |
| SERIES BOther financing | Jun 2024 | $41M | $165M | LongRiver Investments · King Star Med · INCE Capital · Wuxi Guolian Venture Capital | ↗ |
| EARLY VCOther financing | Aug 2023 | $28M | $110M | Notable Capital · Matrix Partners China · Lilly Asia Ventures · NRL Capital | ↗ |
| EARLY VCOther financing | Dec 2022 | $20M | $80M | LRI Jiangyuan Investment · Notable Capital · Matrix Partners China · Vivo Capital | ↗ |
| SERIES AOther financing | Apr 2021 | — | — | Notable Capital · Matrix Partners China · Vivo Capital · Lilly Asia Ventures | — |
| SEEDOther financing | Jan 2020 | Lilly Asia Ventures | — |
Growth signals
Ruilongnuofu Medical Technology website traffic
Latest recorded traffic for Ruilongnuofu Medical Technology is 2K monthly website visits, up 412.8% over the last three months. Ruilongnuofu Medical Technology's team grew 34.4% over the past year.
Hiring
Open positions at Ruilongnuofu Medical Technology
Current openings linked to this company in Dealroom.
Comparisons
Ruilongnuofu Medical Technology compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Ruilongnuofu Medical Technology's talent
Source: Dealroom Talent Intelligence.
Investors
13 investors on Ruilongnuofu Medical Technology's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Global footprint
Where Ruilongnuofu Medical Technology has talent and traffic
team presence
In the news
Latest news about Ruilongnuofu Medical Technology
Recent press, funding announcements, and product moves mentioning Ruilongnuofu Medical Technology — open to read from the original sources.
Market sentiment
What the market is saying about Ruilongnuofu Medical Technology
An AI-synthesized read of the highest-engagement posts about Ruilongnuofu Medical Technology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ruilongnuofu Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.